Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
about
CYP17 inhibitors in prostate cancer: latest evidence and clinical potentialA Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer.Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
P2860
Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Abiraterone for treatment of m ...... atic review and meta-analysis.
@ast
Abiraterone for treatment of m ...... atic review and meta-analysis.
@en
type
label
Abiraterone for treatment of m ...... atic review and meta-analysis.
@ast
Abiraterone for treatment of m ...... atic review and meta-analysis.
@en
prefLabel
Abiraterone for treatment of m ...... atic review and meta-analysis.
@ast
Abiraterone for treatment of m ...... atic review and meta-analysis.
@en
P2093
P1476
Abiraterone for treatment of m ...... atic review and meta-analysis.
@en
P2093
Shi-Xin Liu
Tian-Song Zhang
Zhi-Rui Zhou
P304
P577
2014-01-01T00:00:00Z